➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Mallinckrodt
AstraZeneca
Medtronic
Merck

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

LORATADINE REDIDOSE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Loratadine Redidose patents expire, and when can generic versions of Loratadine Redidose launch?

Loratadine Redidose is a drug marketed by Sun Pharm Inds Ltd and is included in one NDA.

The generic ingredient in LORATADINE REDIDOSE is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and nineteen suppliers are listed for this compound. Additional details are available on the loratadine profile page.

US ANDA Litigation and Generic Entry Outlook for Loratadine Redidose

A generic version of LORATADINE REDIDOSE was approved as loratadine by PLD ACQUISITIONS LLC on January 21st, 2003.

  Start Trial

Summary for LORATADINE REDIDOSE
Drug patent expirations by year for LORATADINE REDIDOSE

US Patents and Regulatory Information for LORATADINE REDIDOSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd LORATADINE REDIDOSE loratadine TABLET, ORALLY DISINTEGRATING;ORAL 077153-001 Apr 11, 2007 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Baxter
AstraZeneca
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.